LEO Pharma buys worldwide dersimelagon rights for up to $435 million
来源：Reuters发布于 2026-08-18
Danish drugmaker LEO Pharma said on Tuesday it had agreed to acquire worldwide rights to drug candidate dersimelagon from Tanabe Pharma for up to $435 million in up-front and near-term milestone pay...
相关标的：LEO
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。